AAVXF:OTCMKTS
Abivax SA
US$139.00
0.00%
(0.00) 1 天
7月9日, GMT-4 09:30:01 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 AAVXF 生成关键数据洞见…
市值
68.32亿
平均成交量
0.00
成交量
0.00
52 周最高价
US$139.00
52 周最低价
US$71.26
Beta 版
3.09
流通股数
8753.00万
员工人数
98
市值
68.32亿
平均成交量
0.00
成交量
0.00
52 周最高价
US$139.00
52 周最低价
US$71.26
Beta 版
3.09
流通股数
8753.00万
员工人数
98
新闻报道
来自网络来源和新闻合作伙伴
资料
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
Abivax SA简介